The effects of transdermal estrogens combined with Medroxyprogesterone Acetate on cardiovascular disease risk factors in postmenopausal women: a meta-analysis of randomized controlled trials

Abstract Background To date, no meta-analysis has reported on the role of transdermal estrogens combined with Medroxyprogesterone Acetate (MPA) in relation to cardiovascular disease (CVD) risk factors in postmenopausal women. To fill this knowledge gap, a meta-analysis of randomized controlled trial...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Fan Zhou, Kousalya Prabahar, Jiao Shu
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2025-04-01
Schriftenreihe:	Diabetology & Metabolic Syndrome
Schlagworte:	Transdermal estrogens combined with oral Medroxyprogesterone acetate Postmenopausal women Lipid profile Cholesterol Triglycerides Apolipoproteins
Online-Zugang:	https://doi.org/10.1186/s13098-025-01664-1
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!